I think where LH goes from here will depend on Q2 earnings. If they meet expectations, the stock should rally strongly, all the way to 36. That would still be cheap in terms of PE, growth prospects, etc. If they do not meet expectations, the stock will take a hit, probably back down to the mid 20's. I suspect they will meet expectations since they haven't warned, but I'm concerned by some things. Health care companies have reported slow business, apparently related to the higher co-pays etcs. Last quarter LH reported slow business. Insiders haven't been buying and analysts are downgrading. I wonder if anybody has a fix on this -- has business looked good or has there been a slowdown in health care utilization? I suspect I am overly concerned about this, but there are just too many loose ends to feel comfortable. Long term situation still looks very good, but if LH falls far short of its numbers, management could lose a lot of credibility that could damage the stock for quite some time. Keep in mind that a miss this quarter would come on top of what happened last year and then management saying that last quarter's slowdown was weather elated. Also, health care is before the congress right now, and will be a big issue in the election, so the group is under a cloud. Health care is seen as a defensive, conservative play and right now the market players are aiming for Bubble II, looking for a killing in tech, which Greenspan seems to be accommodating with his "i'll print all the money it takes to avoid a depression" policy.